Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rayner

Showing results (81-90 of 142) with videos related to

Pageof 15
Sort By:
Antimicrobial Agents and Chemotherapy|June 13, 1998
Initial concentration-time profile of gentamicin determines efficacy against Enterobacter cloacae ATCC 13047C R Rayner, L L Ioannides-Demos, J A Brien, et al.
Antiviral Therapy|May 28, 2015
Safety, virology and pharmacokinetics of oseltamivir in infants with laboratory-confirmed influenza: a Phase I/II, prospective, open-label, multicentre clinical trialBarbara A Rath, Jerzy Brzostek, Sara Guillén, et al.
The British Journal of Dermatology|August 1, 1991
The differentiation and proliferation of newly formed epidermis on wounds treated with cultured epithelial allograftsA M Oliver, W Kaawach, E W Mithoff, et al.
The American Journal of Tropical Medicine and Hygiene|November 25, 2020
The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19Zelyn Lee, Craig R Rayner, Jamie I Forrest, et al.
British Journal of Clinical Pharmacology|September 20, 2006
Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasmaSreeja Sudhakaran, Craig R Rayner, Jian Li, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 31, 2015
Population pharmacokinetic analysis of oseltamivir and oseltamivir carboxylate following intravenous and oral administration to patients with and without renal impairmentLeonid Gibiansky, Mylène Giraudon, Craig R Rayner, et al.
Infection|March 10, 2004
Linezolid in the treatment of osteomyelitis: results of compassionate use experienceC R Rayner, L M Baddour, M C Birmingham, et al.
British Journal of Clinical Pharmacology|December 21, 2007
Inhibition of placental P-glycoprotein: impact on indinavir transfer to the foetusSreeja Sudhakaran, Craig R Rayner, Jian Li, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2015
A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progressionMohamed A Kamal, Ronald Gieschke, Annabelle Lemenuel-Diot, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltrationJ Li, C R Rayner, R L Nation, et al.
Pageof 15

Showing results (81-90 of 142) with videos related to

Sort By:
Pageof 15
Antimicrobial Agents and Chemotherapy|June 13, 1998
Initial concentration-time profile of gentamicin determines efficacy against Enterobacter cloacae ATCC 13047C R Rayner, L L Ioannides-Demos, J A Brien, et al.
Antiviral Therapy|May 28, 2015
Safety, virology and pharmacokinetics of oseltamivir in infants with laboratory-confirmed influenza: a Phase I/II, prospective, open-label, multicentre clinical trialBarbara A Rath, Jerzy Brzostek, Sara Guillén, et al.
The British Journal of Dermatology|August 1, 1991
The differentiation and proliferation of newly formed epidermis on wounds treated with cultured epithelial allograftsA M Oliver, W Kaawach, E W Mithoff, et al.
The American Journal of Tropical Medicine and Hygiene|November 25, 2020
The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19Zelyn Lee, Craig R Rayner, Jamie I Forrest, et al.
British Journal of Clinical Pharmacology|September 20, 2006
Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasmaSreeja Sudhakaran, Craig R Rayner, Jian Li, et al.
Journal of Pharmacokinetics and Pharmacodynamics|March 31, 2015
Population pharmacokinetic analysis of oseltamivir and oseltamivir carboxylate following intravenous and oral administration to patients with and without renal impairmentLeonid Gibiansky, Mylène Giraudon, Craig R Rayner, et al.
Infection|March 10, 2004
Linezolid in the treatment of osteomyelitis: results of compassionate use experienceC R Rayner, L M Baddour, M C Birmingham, et al.
British Journal of Clinical Pharmacology|December 21, 2007
Inhibition of placental P-glycoprotein: impact on indinavir transfer to the foetusSreeja Sudhakaran, Craig R Rayner, Jian Li, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2015
A drug-disease model describing the effect of oseltamivir neuraminidase inhibition on influenza virus progressionMohamed A Kamal, Ronald Gieschke, Annabelle Lemenuel-Diot, et al.
Antimicrobial Agents and Chemotherapy|October 28, 2005
Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltrationJ Li, C R Rayner, R L Nation, et al.
Pageof 15